BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 29068593)

  • 1. Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Janikowski K; Lelonek M
    Adv Clin Exp Med; 2017 Sep; 26(6):931-938. PubMed ID: 29068593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble ST2 protein in the short-term prognosis after hospitalisation in chronic systolic heart failure.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Lelonek M
    Kardiol Pol; 2014; 72(8):725-34. PubMed ID: 24846354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction - A multicenter study.
    Bahuleyan CG; Alummoottil GK; Abdullakutty J; Lordson AJ; Babu S; Krishnakumar VV; Pillai AM; Abraham G; Dilip MN
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S79-S84. PubMed ID: 30122243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure.
    Lombardi C; Carubelli V; Rovetta R; Castrini AI; Vizzardi E; Bondei I; Sciatti E; Manerba A; Benlodi E; Nodari S; Metra M
    Panminerva Med; 2016 Mar; 58(1):8-15. PubMed ID: 26154625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ST2 in heart failure with preserved and reduced ejection fraction.
    Najjar E; Faxén UL; Hage C; Donal E; Daubert JC; Linde C; Lund LH
    Scand Cardiovasc J; 2019 Feb; 53(1):21-27. PubMed ID: 30776920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST2 elevation in heart failure, predictive of a high early mortality.
    Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
    Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure.
    Piper SE; Sherwood RA; Amin-Youssef GF; Shah AM; McDonagh TA
    Int J Cardiol; 2015 Jan; 178():284-91. PubMed ID: 25465308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble ST2 proteins in male cachectic patients with chronic heart failure.
    Sobieszek G; Powrózek T; Jaroszyński A; Skwarek-Dziekanowska A; Rahnama-Hezavah M; Małecka-Massalska T
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):886-893. PubMed ID: 33549461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single sST2 protein measurement predicts adverse outcomes at 1-year follow-up in patients with chronic heart failure.
    Sobczak S; Wojtczak-Soska K; Ciurus T; Sakowicz A; Pietrucha T; Lelonek M
    Pol Arch Med Wewn; 2014; 124(9):452-8. PubMed ID: 25041760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness of Outpatient Treatment Under the Control of the Soluble ST2 Receptor Concentration in Patients With Heart Failure With Reduced Ejection Fraction After Acute Decompensation of Heart Failure.
    Muksinova MD; Narusov OY; Sychev AV; Sharf TV; Masenko VP; Tereshchenko SN; Skvortsov AA
    Kardiologiia; 2023 Dec; 63(12):87-92. PubMed ID: 38156496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of ST2 in patients with chronic heart failure of ischemic etiology and carbohydrate metabolism disorders.
    Grakova EV; Kopeva KV; Teplyakov AT; Ogurkova ON; Garganeeva AA; Garmaeva OV
    Ter Arkh; 2019 Mar; 91(1):32-37. PubMed ID: 31090368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of mortality in patients hospitalized for congestive heart failure with left ventricular ejection fraction ≥ 40.
    Sherazi S; McNitt S; Choudhary N; Shah AH; Aktas MK; Asgher A; Schwarz KQ; Zareba W
    Cardiol J; 2015; 22(4):382-90. PubMed ID: 25588532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IVC diameter in patients with chronic heart failure: relationships and prognostic significance.
    Pellicori P; Carubelli V; Zhang J; Castiello T; Sherwi N; Clark AL; Cleland JG
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):16-28. PubMed ID: 23328557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.
    Pascual-Figal DA; Ordoñez-Llanos J; Tornel PL; Vázquez R; Puig T; Valdés M; Cinca J; de Luna AB; Bayes-Genis A;
    J Am Coll Cardiol; 2009 Dec; 54(23):2174-9. PubMed ID: 19942089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology.
    Broch K; Ueland T; Nymo SH; Kjekshus J; Hulthe J; Muntendam P; McMurray JJ; Wikstrand J; Cleland JG; Aukrust P; Gullestad L
    Eur J Heart Fail; 2012 Mar; 14(3):268-77. PubMed ID: 22302661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NGAL and ST2 levels in ambulatory patients with chronic heart failure. Clinical and echocardiographic correlates.
    Ventoulis I; Mantziari L; Mouratoglou SA; Kamperidis V; Giannakoulas G; Ziakas A; Tsalikakis D; Giamouzis G; Hitoglou-Makedou A; Karvounis H
    Scand Cardiovasc J; 2015 Aug; 49(4):213-9. PubMed ID: 25919009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic Variability of Soluble ST2 in Patients With Stable Chronic Heart Failure and Implications for Monitoring.
    Piper S; deCourcey J; Sherwood R; Amin-Youssef G; McDonagh T
    Am J Cardiol; 2016 Jul; 118(1):95-8. PubMed ID: 27189812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble ST2 and brain natriuretic peptide predict different mode of death in patients with heart failure and preserved ejection fraction.
    Sugano A; Seo Y; Ishizu T; Sai S; Yamamoto M; Hamada-Harimura Y; Machino-Ohtsuka T; Obara K; Nishi I; Aonuma K; Nogami A
    J Cardiol; 2019 Apr; 73(4):326-332. PubMed ID: 30580891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.